Study S002352

The Efficacy of Mallya in Type 2 Diabetes Transiting From Oral Antidiabetic Drugs to iGlarLixi: a Randomized Controlled Trial Using Real-time Continuous Glucose Monitoring

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05591391
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: UNKNOWN
Enrollment: 40
Start: 2022-09-28
Primary completion: 2025-06-30
Lead sponsor: Taipei Veterans General Hospital, Taiwan
Conditions: Mallya
Interventions: OTHER:Mallya cap; OTHER:Standard care
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Time in range [7 days of CGM data]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.